ANA M APARICIO
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology HOUSTON, TX NPI 1720033657
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX Astellas Pharma US Inc All categories
General Payments — all program years on this page
$61,274.27
- Category: General Payments
- Program years: PY2018–2024
- Record count: 99
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $24,874.97 across 34 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $19,435.50 | 9 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,450.00 | 1 |
| Travel and Lodging | $1,516.89 | 4 |
| Food and Beverage | $1,472.58 | 20 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $7,770.48 | 7 |
| GlaxoSmithKline, LLC. | $3,140.83 | 4 |
| PFIZER INC. | $2,561.44 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $2,163.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $2,099.52 | 3 |
| Janssen Research & Development, LLC | $2,000.00 | 2 |
| Astellas Pharma Global Development | $1,860.00 | 1 |
| Daiichi Sankyo Inc. | $1,749.83 | 3 |
| Janssen Scientific Affairs, LLC | $953.58 | 2 |
| MACROGENICS, INC. | $155.65 | 2 |
| Regeneron Healthcare Solutions, Inc. | $133.09 | 1 |
| Janssen Biotech, Inc. | $124.32 | 1 |
| Dendreon Pharmaceuticals LLC | $72.42 | 3 |
| Astellas Pharma Europe BV | $71.55 | 1 |
| AVEO Pharmaceuticals, Inc. | $19.26 | 1 |
By program year
Records — PY2024 (34)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.